ODT ($4.78) -75% A good reminder that insider buys don't necessarily mean anything, especially on unprofitable drug stocks seeking FDA approval for their one drug. Sometimes insiders in such stocks are just drinking their own Kool-aid.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.